DE3887194T2 - Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. - Google Patents

Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.

Info

Publication number
DE3887194T2
DE3887194T2 DE3887194T DE3887194T DE3887194T2 DE 3887194 T2 DE3887194 T2 DE 3887194T2 DE 3887194 T DE3887194 T DE 3887194T DE 3887194 T DE3887194 T DE 3887194T DE 3887194 T2 DE3887194 T2 DE 3887194T2
Authority
DE
Germany
Prior art keywords
production
therapeutic use
platinum complexes
antitumor platinum
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3887194T
Other languages
English (en)
Other versions
DE3887194D1 (de
Inventor
Yokio Sugimura
Yukiko Kameyama
Toshihiko Hashimoto
Kimio Iino
Tomoyuki Shibata
Shigeki Muramatsu
Tomowo Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE3887194D1 publication Critical patent/DE3887194D1/de
Application granted granted Critical
Publication of DE3887194T2 publication Critical patent/DE3887194T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
DE3887194T 1987-05-08 1988-05-06 Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. Expired - Fee Related DE3887194T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11218187 1987-05-08
JP11450087 1987-05-13

Publications (2)

Publication Number Publication Date
DE3887194D1 DE3887194D1 (de) 1994-03-03
DE3887194T2 true DE3887194T2 (de) 1994-07-28

Family

ID=26451415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887194T Expired - Fee Related DE3887194T2 (de) 1987-05-08 1988-05-06 Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.

Country Status (13)

Country Link
US (2) US5527905A (de)
EP (1) EP0290280B1 (de)
KR (1) KR950008372B1 (de)
CN (1) CN1017803B (de)
AU (1) AU617314B2 (de)
CA (1) CA1308723C (de)
DE (1) DE3887194T2 (de)
DK (1) DK252688A (de)
ES (1) ES2061646T3 (de)
FI (1) FI87572C (de)
HU (1) HU199492B (de)
NO (1) NO178069C (de)
RU (1) RU2039064C1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0164460B1 (ko) * 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
EP2266607A3 (de) 1999-10-01 2011-04-20 Immunogen, Inc. Immunokonjugate für Krebsbehandlung
JP2003513756A (ja) * 1999-11-12 2003-04-15 アンジオテック ファーマシューティカルズ，インコーポレイテッド 放射性治療と細胞周期インヒビターとの組合せの組成物
KR100363394B1 (ko) 2000-08-21 2002-12-05 한국과학기술연구원 온도감응성을 갖는 포스파젠삼량체-백금착물 복합체, 그의제조방법 및 그를 함유하는 항암제 조성물
US20040225077A1 (en) 2002-12-30 2004-11-11 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
CA2807823C (en) 2010-08-24 2023-02-07 The Brigham And Women's Hospital, Inc. Methods for predicting anti-cancer response
WO2012174378A2 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
AU2012358244A1 (en) 2011-12-21 2014-06-12 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
DK2817630T3 (en) 2012-02-23 2018-10-08 Childrens Medical Center Methods for predicting an anti-cancer response
CA3190075A1 (en) 2012-06-07 2013-12-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
WO2015086473A1 (en) 2013-12-09 2015-06-18 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
DK3180447T3 (da) 2014-08-15 2020-06-15 Myriad Genetics Inc Fremgangsmåder og materialer til analyse af homolog rekombinationsdeficiens
CN111721842B (zh) * 2019-03-19 2022-07-12 海南长安国际制药有限公司 洛铂中有关物质的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
GB2019397B (en) * 1978-04-20 1982-10-27 Johnson Matthey Co Ltd Pt 2 and 4 complexes with amino-acids
IL67789A (en) * 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
DK166825B1 (da) * 1985-09-06 1993-07-19 Sankyo Co Antitumor-platinkomplekser og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DE3630497A1 (de) * 1986-09-08 1988-03-10 Behringwerke Ag Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
DE3887194D1 (de) 1994-03-03
NO882012D0 (no) 1988-05-09
RU2039064C1 (ru) 1995-07-09
DK252688D0 (da) 1988-05-06
EP0290280A2 (de) 1988-11-09
HUT47301A (en) 1989-02-28
FI882130A0 (fi) 1988-05-06
CA1308723C (en) 1992-10-13
US5633243A (en) 1997-05-27
ES2061646T3 (es) 1994-12-16
KR880013961A (ko) 1988-12-22
DK252688A (da) 1988-11-09
CN1017803B (zh) 1992-08-12
KR950008372B1 (ko) 1995-07-28
HU199492B (en) 1990-02-28
EP0290280B1 (de) 1994-01-19
AU1581388A (en) 1988-11-10
CN1034544A (zh) 1989-08-09
FI87572C (fi) 1993-01-25
EP0290280A3 (en) 1990-07-25
FI882130A (fi) 1988-11-09
FI87572B (fi) 1992-10-15
NO882012L (no) 1989-02-27
AU617314B2 (en) 1991-11-28
NO178069C (no) 1996-01-17
NO178069B (no) 1995-10-09
US5527905A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
DE3687646T3 (de) Biosensor und dessen herstellung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE3674089D1 (de) Thiazolidin-derivate, deren herstellung und verwendung.
DE3887194D1 (de) Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3687130D1 (de) Pyrazolderivate, deren herstellung und verwendung.
DE3879024D1 (de) Pyridinium-derivate, ihre herstellung und verwendung.
DE3688477D1 (de) Antibakterielle verbindungen, ihre herstellung und verwendung.
ATE73762T1 (de) N-aminobutyl-n-phenylarylamid-derivate, ihre herstellung und ihre verwendung in der heilkunde.
DE3784602T2 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3669518D1 (de) Vollaromatische polyester, deren herstellung und verwendung.
DE3673587D1 (de) Magnetronanode und deren herstellung.
DE3581210D1 (de) Immunotoxin und herstellung.
DE3886382D1 (de) Wärmestabiles cyclodextrin glycosyl-transferase, deren herstellung und verwendung.
DE3883297D1 (de) Phenolderivate, ihre herstellung und verwendung.
DE3865073D1 (de) Imidazopyridinderivate, ihre herstellung und therapeutische verwendung.
DE3789352D1 (de) Neue biphenylabkömmlinge, deren herstellung und verwendung.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
DE68904336T2 (de) Anti-humankrebsproteinkomplexe, deren herstellung und verwendung.
DE3770299D1 (de) 1,2,4-triazinonderivate, ihre herstellung und verwendung.
ATE100456T1 (de) Antitumor-platinkomplexe, deren herstellung und deren therapeutische verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee